loading page

Applied use of venovenous extracorporeal membrane oxygenation support in severe septic shock and sepsis induced cardiomyopathy with unknown etiology pneumonia: a case report
  • +1
  • Fengyuan Li,
  • Lin Yang,
  • Jiahao Chen,
  • Qiang Guo
Fengyuan Li
The First Affiliated Hospital of Soochow University
Author Profile
Lin Yang
The First Affiliated Hospital of Soochow University
Author Profile
Jiahao Chen
The First Affiliated Hospital of Soochow University
Author Profile
Qiang Guo
The First Affiliated Hospital of Soochow University
Author Profile

Abstract

BACKGROUD: There is no consensus over the effect of V-V ECMO on septic patients with sepsis-induced cardiomyopathy. CASE PRESENTATION: A 48-year-old male was transferred to our emergency department for acute-onset fever lasting for four days on November 1, 2019. He traveled in many places in northern China (Yan’an, Beijing, Qinhuangdao and so on) one month prior to admission. We initiated V-V ECMO on day 2. The patient’s hemodynamics and infection condition improved. After detecting of nasopharyngeal swabs and bronchoalveolar lavage samples, A/H1N1 influenza, influenza B, coronavirus, System Inflammatory Reaction Syndrome (SIRS), Middle East respiratory syndrome (MERS) and other epidemic disease were ruled out. On the day 22, patient’s pulmonary images findings revealed the recover. He was transferred to a regular room discharged soon. CONCLUSION: The outcome of our patient shows that V-V ECMO may also benefit the patient when managing septic shock and septic cardiomyopathy.